Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerman AB (1997) Psoriasis. In: Ackerman AB (ed) Histologic diagnosis of inflammatory skin diseases. An algorithmic method based on pattern analysis. Lippincott Williams and Wilkins, Baltimore, pp 663–673
Ackermann L, Harvima IT, Pelkonen J, RitamakiSalo V, Naukkarinen A, Harvima RJ, Horsmanheimo M (1999) Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 140: 624–633
Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113: 752–759
Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, Rosbotham JL, Little AM, Madrigal A, Barker JN, Powis SH, Trembath RC (1999) Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 113: 322–328
Barker JN (2001) Genetic aspects of psoriasis. Clin Exp Dermatol 26: 321–325
Bianchi L, Farrace MG, Nini G, Piacentini M (1994) Abnormal Bcl-2 and “tissue” transglutaminase expressio in psoriatic skin. J Invest Dermatol 103: 829–833
Biondi Oriente C, Scarpa R, Pucino A, Oriente P (1989) Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl (Stockh) 146: 69–71
Boehncke WH, Sterry W, Hainzl A, Scheffold W, Kaufmann R (1994) Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice. Arch Dermatol Res 286: 325–330
Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R (1996) Psoriatic onycho-pachydermo-periostitis. A variant of psoriatic distal interphalangeal arthritis? Arch Dermatol 132: 176–180
Bos JD (1988) The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol 118: 141–155
Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 10: 1793–1805
Boyman O, Hefti HP, Suter M, Nickoloff BJ, Nestle FO (2002) TBA-alpha-dependent induction of psoriasis in the absence of lymphocyte recruitment. Br J Dermatol 147: 1047–1078
Braun-Falco O (1991) Psoriasis vulgaris. In: Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK (eds) Dermatology. Springer, Berlin Heidelberg New York, pp 417–437
Burden AD (2000) Identifying a gene for psoriasis on chromosome 6 (Psors1). Br J Dermatol 143: 238–241
Cai JP, Harris K, Falanga V, Taylor JR, Chin YH (1996) UVB therapy decreases the adhesive interaction between peripheral blood mononuclear cells and dermal microvascular endothelium, and regulates the differential expression of CD54, VCAM-1, and E-selectin in psoriatic plaques. Br J Dermatol 134: 7–16
Champion RH (1986) Psoriasis. Br Med J (Clin Res Ed) 292: 1693–1696
Cheng L, Zhang SZ, Xiao CY, Hou YP, Li L, Luo HC, Jiang HY, Zuo WQ (2000) The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br J Dermatol 143: 324–329
Chin YH, Falanga V, Taylor JR, Cai JP, Bax J (1990) Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium. J Invest Dermatol 94: 413–417
Christophers E, Henseler T (1985) Characterization of disease patterns in nonpustular psoriasis. Semin Dermatol 4: 271–275
Christophers E, Mrowietz U (1999) Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K (eds) Dermatology in general medicine, 5th edn. McGraw Hill, New York, pp 495–521
Creamer JD, Barker JN (1995) Vascular proliferation and angiogenic factors in psoriasis. Clin Exp Dermatol 20: 6–9
Curry JL, Qin J-Z, Bonish B, Carrick R, Bacon P, Panella J, Robinson J, Nickoloff BJ (2003) Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 127: 178–186
Daoud P, Mirc M, Tarazourte MF, Pollak M, Rousset A, Castaing H (2000) Neonatal hyperparathyroidism secondary to unknown maternal hypoparathyroidism. Arch Pediatr 7: 45–48
Dover R, Wright NA (1993) Biology and function of epidermis and appendages. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine. McGraw-Hill, New York, p 159
Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: a role for p50. Clin Exp Immunol 135: 64–73
Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29: 428–434
Ekholm E, Egelrud T (1999) Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 291: 195–200
Elder JT, Nair RP, Voorhees JJ (1994) Epidemiology and the genetics of psoriasis. J Invest Dermatol 102: 24S–27S
Favre M, Majewski S, Noszczyk B, Maienfisch F, Pura A, Orth G, Jablonska S (2000) Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 114: 403–407
Gillitzer R, Ritter U, Spandau U, Goebeler M, Brocker EB (1996) Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 107: 778–782
Gillum PS, Golitz LE (1998) Psoriasiform dermatitis. In: Barnhill RL (ed) Textbook of dermatopathology. McGraw Hill, New York, pp 55–68
Gonzalez S, Martinez-Borra J, Del Rio JS, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, Lopez-Larrea C (2000) The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol 115: 824–828
Goodfield M, Macdonald Hull SM, Holland D, Roberts G, Wood E, Reid S (1994) Investigations of the ‘active’ edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin. Br J Dermatol 131: 808–813
Gordon M, Johnson WC (1967) Histopathology and histochemistry of psoriasis: I. The active lesion and clinically normal skin. Arch Dermatol 95: 402–407
Griffiths CE (1994) Cutaneous leukocyte trafficking and psoriasis. Arch Dermatol 130: 494–499
Haase I, Pasparakis M (2002) A new mouse model for psoriasis: evidence for a TNF-mediated, T cell-independent pathogenesis. Br J Dermatol 47: 1047–1078
Herbst RA, Hoch O, Kapp A, Weiss J (2000) Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. J Am Acad Dermatol 42: 885–887
Irimajiri J, Yamamoto T, Rimura K, Yokozeki H, Nishioka K (1998) Verruca vulgaris developing during cyclosporin therapy for psoriasis vulgaris. J Dermatol 25: 688–690
Kere J (2002) PSORS1: towards gene identification. Br J Dermatol 147: 1047–1078
Kono T, Tanii T, Furukawa M, Mizuno N, Taniguchi S, Ishii M, Hamada T (1990) Effects of human recombinant tumor necrosis factor-alpha (TNF-alpha) on the proliferative potential of human keratinocytes cultured in serum-free medium. J Dermatol 17: 409–413
Krueger GG, Eyre RW (1984) Trigger factors in psoriasis. Dermatol Clin 2: 373–381
Kulke R, Bornscheuer E, Schluter C, Bartels J, Rowert J, Sticherling M, Christophers E (1998) The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 110: 90–94
Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN (1995) Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 133: 501–511
Leung D, Walsh P, Giorno R, Norris D (1993) A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100: 225–228
Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ (1995) Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyteassociated antigen via stimulation of interleukin 12 production. J Exp Med 181: 747–753
Linhart C, Wolter M, Kaufmann R (2003) Psoriasiforme entzündliche Dermatosen. In: Kerl H, Garbe C, Cerroni L, Wolff HH (eds) Histopathologie der Haut, 1st edn. Springer, Berlin Heidelberg New York, pp 145–150
Lowe PM, Lee ML, Jackson CJ, To SS, Cooper AJ, Schrieber L (1995) The endothelium in psoriasis. Br J Dermatol 132: 497–505
Ludolph-Hauser D, Schubert C, Wiedow O (1999) Structural changes of human epidermis induced by human leukocyte-derived proteases. Exp Dermatol 8: 46–52
Mahe E, Bodemer C, Descamps V, Mahe I, Crickx B, De Prost Y, Favre M (2003) High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Br J Dermatol 149: 819–825
Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R, Bunker CB (1998) HLA-Cw*0602 and HIV-associated psoriasis. Br J Dermatol 139: 527–533
Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F, Bunker CB (2000) HLA-C and guttate psoriasis. Br J Dermatol 143: 1177–1182
Molhuizen HO, Schalkwijk J (1995) Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol Chem Hoppe Seyler 376: 1–7
Mommers JM, van Rossum MM, van Erp PE, van de Kerkhof PC (2000) Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology 201: 15–20
Moynihan GD, Ruppe JP Jr (1985) Impetigo herpetiformis and hypoparathyroidism. Arch Dermatol 121: 1330–1331
Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66: 1833–1844
Naldi L, Peli L, Parazzini F, Carrel CF, Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology (2001) Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: Results of a case-control study. J Am Acad Dermatol 44: 433–438
Nanney LB, Yates RA, King LE Jr (1992) Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topicals EGF. J Invest Dermatol 98: 296–301
Navarro JM, Casatorres J, Jorcano JL (1995) Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem 270: 21362–21367
Nickoloff BJ (1999) The immunologic and genetic basis of psoriasis. Arch Dermatol 135: 1104–1110
Nickoloff BJ, Wrone-Smith T (1998) Superantigens, autoantigens, and pathogenic T cells in psoriasis. J Invest Dermatol 110: 459–460
Penas PF, Gomez M, Buezo GF, Rios L, Yanez-Mo M, Cabanas C, Sanchez-Madrid F, Garcia-Diez A (1998) Differential expression of activation epitopes of beta1 integrin in psoriasis and normal skin. J Invest Dermatol 111: 19–24
Petzelbauer P, Pober JS, Keh A, Braverman IM (1994) Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J Invest Dermatol 103: 300–305
Piepkorn M (1996) Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin disease. Am J Dermatopathol 18: 165–171
Plant D, Lear J, Marsland A, Worthington J, Griffiths CEM (2002) NOD2 single nucleotide polymorphisms do not confer susceptibility to chronic plaque psoriasis. Br J Dermatol 147: 1047–1078
Prinz JC (1999) Which T cells cause psoriasis? Clin Exp Dermatol 24: 291–295
Prinz JC (2001) Psoriasis vulgaris, a sterile antibacterial skin reaction, mediated by cross-reactive Tcells? An immunological view on the pathophysiology of psoriasis. Clin Exp Dermatol 26: 326–332
Rajendran SS, Premalatha S, Yesudian P, Zahra A (1984) Psoriasis verruciformis. Int J Dermatol 23: 552–553
Russell TJ, Schultes LM, Kuban DJ (1972) Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 287: 738–740
Sayama K, Midorikawa K, Hanakawa Y, Sugai M, Hashimoto K (1998) Superantigens production by Staphylococcus aureus in psoriasis. Dermatology 196: 194–198
Schalkwijk J, Chang A, Janssen P, de Jongh GJ, Mier PD (1990) Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol 122: 631–641
Schroder JM, Gregory H, Young J, Christophers E (1992) Neutrophil-activating proteins in psoriasis. J Invest Dermatol 98: 241–247
Skov L, Baadsgaard O (2000) Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol 25: 57–61
Smith CH, Barker JNWN (1995) Cell trafficking and role of adhesion molecules in psoriasis. In: van de Kerkhof PCM, Bos JD (eds) Pathogenetic aspects of psoriasis. Elsevier, New York, pp 151–160
Snowden JA, Heaton DC (1997) Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 137: 130–132
Steffen C (2002) William John Munro and Munro’s abscess, and Franz Kogoj and Kogoj’s spongiform pustule. Am J Dermatopathol 24: 364–368
Swanbeck G, Inerot A, Martinsson T, Wahlstrom J, Enerback C, Enlund F, Yhr M (1995) Age at onset and different types of psoriasis. Br J Dermatol 133: 768–773
Sweet WL, Smoller BR (1997) Differential proliferation of endothelial cells and keratinocytes in psoriasis and spongiotic dermatitis. J Cutan Pathol 24: 356–363
Szepietowski J, Wasik F, Bielicka E, Nockowski P, Noworolska A (1999) Soluble E-selectin serum levels correlate with disease activity in psoriasis patients. Clin Exp Dermatol 24: 33–36
Takematsu H, Tagami H (1993) Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 129: 74–80
Tanaka N, Fujioka A, Tajima S, Ishibashi A, Hirose S (2000) Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1beta and tumor necrosis factor-alpha stimulate its secretion in vitro. Br J Dermatol 143: 728–732
Telfer NR, Chalmers RJ, Whale K, Colman G (1992) The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 128: 39–42
Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M (1980) Psoriasis and HLA-Cw6. Br J Dermatol 102: 179–184
Travis L, Weinberg JM (2002) Medical background: Psoriasis. Drugs Today (Barc) 38: 847–865
Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L (1995) Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16: 145–149
Van de Kerkhof PCM (1986) Clinical features. In: Mier PD, van der Kerkhof PCM (eds) Textbook of psoriasis. Churchill Livingstone, Edinburgh, pp 13–39
Van de Kerkhof PCM (2003) Psoriasis. In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mancini AJ, Mascaro JM, Salasche SJ, Saurat JH, Stingl G (eds) Dermatology. Mosby, St. Louis, pp 125–149
Van de Kerkhof PCM, Gerritsen MJP, de Jong EMGJ (1996) Transition from symptomless to lesional psoriatic skin. Clin Exp Dermatol 21: 325–329
Van der Fits L, Van der Wel LI, Boogaard MW, Laman JD, Versuchen MCM, Prens EP (2002) Type I and Type II interferon signalling are both activated in lesional psoriatic skin. Br J Dermatol 147: 1047–1078
Wakita H, Takigawa M (1994) E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 130: 457–463
Watts P, Stables GS, Akhurst RJ, MacKie RM (1994) Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy. Br J Dermatol 131: 64–71
Weedon D (2002) The psoriasiform reaction pattern. In: Weedon D (ed) Skin pathology. Churchill Livingstone, London, pp 76–83
Weinstein GD, Van Scott EJ (1965) Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J Invest Dermatol 45: 257–262
Wiedow O, Schroder J-M, Gregory H, Young JA, Christophers E (1990) Elafin: An elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 265: 14791–14795
Wiedow O, Wiese F, Streit V, Kalm C, Christophers E (1992) Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol 99: 306–309
Wiedow O, Wiese F, Christophers E (1995) Lesional activity in psoriasis. Diagnostic and prognostic significance. Arch Dermatol Res 287: 632–635
Young HS, Summers AM, Bhushan M, Brenchley PEC, Griffiths CE (2004) Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122: 209–215
Zhou S, Matsuyoshi N, Takeuchi T, Ohtsuki Y, Miyachi Y (2003) Reciprocal altered expression of T-cadherin and P-cadherin in psoriasis vulgaris. Br J Dermatol 149: 268–273
Zimmerman GM (1999) Alcohol and psoriasis. Arch Dermatol 135: 1541–1542
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Prinz Vavricka, B.M., Guitart, J. (2005). Psoriasis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_10
Download citation
DOI: https://doi.org/10.1007/3-540-27190-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21280-5
Online ISBN: 978-3-540-27190-1
eBook Packages: MedicineMedicine (R0)